Inactive Instrument

Genetron Holdings Limited

GTH

US37186H2094

Biotechnology & Medical Research

Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index

March 28, 2024

Genetron Holdings Limited has been removed from NASDAQ Composite Index .

Latest news about Genetron Holdings Limited

Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index	Mar. 28	CI
New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited	Mar. 27	CI
ADRs End Lower; Saverone 2014 Ltd. Declines 17.7%	23-10-12	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	23-10-12	MT
Sector Update: Health Care	23-10-12	MT
North American Morning Briefing : Hopes A Mild Inflation Print Will Keep Fed on Hold	23-10-12	DJ
Genetron Holdings Signs Merger Agreement to Go Private; Shares Soar Premarket	23-10-12	MT
Genetron Holdings Signs Merger Agreement to Go Private	23-10-11	MT
New Genetron Holding Limited agreed to acquire Genetron Holdings Limited for $130 million.	23-10-10	CI
Genetron Gets Nasdaq Notification Regarding Minimum Bid Price Requirement	23-05-23	MT
Genetron Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-12	CI
American Depositary Receipts of Asian Stocks Lower Amid Banking Sector Worries	23-03-27	MT
Genetron Holdings Regains Compliance With Nasdaq's Listing Rule	23-01-18	MT
Earlier US Stock Market Losses Weighed on Asian Equities	22-12-28	MT
Genetron Holdings Receives Non-Compliance Notice from Nasdaq	22-11-07	MT
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Reports Q2 Loss $-0.38	22-10-12	MT
Genetron Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-10-12	CI
Asian ADRs Decline in Monday Trading	22-09-26	MT
Genetron Holdings Limited(NasdaqGM:GTH) dropped from S&P Global BMI Index	22-09-19	CI
Sector Update: Health Care Stocks Decline Premarket Monday	22-08-22	MT
Genetron Gets Non-Binding Takeover Offer from CEO	22-08-22	MT
Sizhen Wang made a non binding proposal to acquire the remaining 49.2% stake in Genetron Holdings Limited from Genetron Health (Hong Kong) Company Limited and others for $60 million.	22-08-21	CI
Genetron Holdings Limited Provides Revenue Guidance for the Year 2022	22-06-02	CI
Transcript : Genetron Holdings Limited, Q1 2022 Earnings Call, Jun 02, 2022	22-06-02
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Posts Q1 Revenue $17.40M	22-06-02	MT

Chart Genetron Holdings Limited

Duration

Period

More charts

Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Sector

Biotechnology & Medical Research

Calendar

2024-05-19 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.69%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.24%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.12%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.22%	18.12B
MEDPACE HOLDINGS, INC.	+30.30%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.34%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.14%	11B

Other Biotechnology & Medical Research